Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

RAPID Imaging Platform Powers Mobile Stroke Units

November 29, 2018

MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 29, 2018--iSchemaView, the worldwide leader in advanced imaging for stroke, today announced that the RAPID imaging platform is now fully compatible with the imaging hardware in use in Mobile Stroke Units (MSU). RAPID is the imaging solution of choice for the mobile stroke unit of Houston’s Memorial Hermann Healthcare System — the very first MSU in the nation.

The Mobile Stroke Unit is a specialized ambulance for prehospital stroke treatment, which provides the diagnostic tools and stroke expertise to enable therapeutic treatment at the site of the emergency. When treated in a Mobile Stroke Unit, patients can be evaluated, imaged and treated before they are transported via ambulance to the emergency department, and data suggests that prehospital treatment can save a critical hour — almost doubling the odds of a patient being discharged directly to home after their stroke. It is expected that patients treated on the MSU will have fewer long-term disabilities, providing them with a better quality of life and potentially reducing overall healthcare costs.

“This novel model for delivering acute stroke treatment is advancing stroke care in Houston and has the potential for broad impact across the nation,” said Dr. James Grotta, Director of Stroke Research for the Clinical Institute for Research and Innovation at the Memorial Hermann–Texas Medical Center and Director of the Mobile Stroke Unit Consortium. “iSchemaView’s RAPID is an important tool to speed our ability to properly triage patients.”

Since 2014, the number of Mobile Stroke Units in the United States has grown to more than 17, with three additional units soon to become operational. RAPID is compatible with all MSUs, regardless of hardware solution.

Developed by leading stroke experts, RAPID combines unmatched expert feature extraction, proprietary algorithms and machine learning to deliver the best-in-class platform, which includes tools for CT perfusion, MR diffusion and perfusion, CT angiography and CT ASPECT scoring. RAPID modules feature custom notifications, custom thresholding, hypoperfusion and cerebral blood volume indexes and golden hour thresholds. And RAPID is the only system which delivers results to mobile devices in less than 90 seconds, whether by email or hospital PACS.

About iSchemaView

iSchemaView is the world-wide leader in advanced imaging for stroke. Installed in over 700 hospitals and stroke centers, iSchemaView’s RAPID (automated CTP, MR, CTA and ASPECTS) is the most advanced stroke imaging platform. In clinical trials, under IRB, RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world. For more information, visit www.iRAPID.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181129005221/en/

CONTACT: Peter Evers

Natron Communications

(415) 524-8899




SOURCE: iSchemaView

Copyright Business Wire 2018.

PUB: 11/29/2018 09:00 AM/DISC: 11/29/2018 09:01 AM


All contents © copyright 2019 The Associated Press.All rights reserved.